ALGERI, Laura
ALGERI, Laura
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming
2020-01-01 Incorvaia L.; Fanale D.; Badalamenti G.; Brando C.; Bono M.; De Luca I.; Algeri L.; Bonasera A.; Corsini L.R.; Scurria S.; Iovanna J.L.; Russo A.; Bazan V.
Deep Learning Networks for Automatic Retroperitoneal Sarcoma Segmentation in Computerized Tomography
2022-02-05 Salvaggio G.; Cutaia G.; Greco A.; Pace M.; Salvaggio L.; Vernuccio F.; Cannella R.; Algeri L.; Incorvaia L.; Stefano A.; Galia M.; Badalamenti G.; Comelli A.
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)
2021-01-01 Incorvaia L.; Badalamenti G.; Fanale D.; Vincenzi B.; Luca I.D.; Algeri L.; Barraco N.; Brando C.; Bonasera A.; Bono M.; Castiglia M.; Cancelliere D.; Cani M.; Rita Corsini L.; Fiorino A.; Galvano A.; Pedone E.; Perez A.; Pivetti A.; Graceffa G.; Pantuso G.; Cabibi D.; Russo A.; Bazan V.
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival?
2021-01-01 Fanale D.; Incorvaia L.; Badalamenti G.; De Luca I.; Algeri L.; Bonasera A.; Corsini L.R.; Brando C.; Russo A.; Iovanna J.L.; Bazan V.
Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement
2022-03-01 Badalamenti G.; Incorvaia L.; Algeri L.; Bonasera A.; Dimino A.; Scalia R.; Cucinella A.; Madonia G.; Pomi F.L.; Galvano A.; Gristina V.; Toia F.; Cordova A.; Bazan V.; Russo A.